Charles River Laboratories | CRL - 销售收入



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 9.43B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


销售 更改 日
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.04B 10M 2026-03
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Cardinal Health USD 60.9B 4.73B 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cigna USD 68.52B 3.95B 2026-03
Concord Medical Services Hldg CNY 200.61M 83.9M 2025-06
CVS Health USD 100.4B 5.3B 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Elevance Health USD 49.5B 200M 2026-03
Humana USD 39.65B 7.13B 2026-03
Illumina USD 1.09B 70M 2026-03
Incyte USD 1.27B 240M 2026-03
Intrexon USD 717K 511K 2024-06
IQVIA Holdings USD 4.15B 210M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
McKesson USD 92.3B 13.86B 2026-03
Merck EUR 5.13B 120M 2026-03
Mettler Toledo International USD 947.13M 182.87M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Revvity USD 711M 61.06M 2026-03
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
UnitedHealth USD 111.7B 1.5B 2026-03
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.27B 338M 2026-03
West Pharmaceutical Services USD 844.9M 39.9M 2026-03